DDIT3 and pancreatic neoplasm: Although the pharmacological induction of ER stress has yet to be investigated in combination with radiation therapy in pancreatic cancer, activating the CHOP-mediated apoptosis pathway through ER stress-inducing agents may potentially sensitize pancreatic cancer tumors to radiation and improve response rates.